×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [tyrosine kinase domain]
Acute Leukemia and the FLT3 Receptor By: Betty Sa’ Mentor: Dr. Govind Bhagat Site: Columbia University Vanderbilt Clinic
213 views
Jon Trent, MD, PhD Assistant Professor Dept. of Sarcoma Medical Oncology The University of Texas, M. D. Anderson Cancer Center
[email protected]
Gastrointestinal
215 views
Specificity Amplification Transient Reversible Cell Proliferation Cell Differentiation Cell Transformation Cell Apoptosis Cell Migration Cell Aging Cell
252 views
Tyrosine Kinase Inhibitors PHL 425 Dr. Mohamed M. Sayed-AShmed
227 views
Controlling Cancer
46 views
Targeted therapy: Falso mito o reale innovazione? Stefano Iacobelli Cancer Clinic & Laboratory of Molecular Oncology Consorzio Interuniversitario Nazionale
220 views
Epilepsy and the EFHC1 Gene
26 views
Cut Off Median IHC
42 views
The Therapeutic I mplications of EML4/ALK, ROS-1 and Other N ew Biomarkers
68 views
Alessandro M. Vannucchi Section of Hematology , University of Florence, Italy
62 views
Friedrich Overkamp 1. GEPARQUINTO (neoadjuvant) N=30 (21+9) GEPARQUINTO (neoadjuvant) N=30 (21+9) TEACH (Lapatinib adjuvant) N=8 TEACH (Lapatinib adjuvant)
224 views
< Prev